Publications 2026

1. Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.  Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K; D:A:D; RESPOND collaborations.
   EClinicalMedicine. 2026;91:103739.  Abstract

2. Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. Kraef C, Ryom L, Kirk O; writing group and the RESPOND study group.
   Eur Respir J. 2026;67(3):2502523.  Abstract

3. In press: CD4 Cell Count Trends After the Common Cancers in People With HIV: A Multicohort Collaboration Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Borges A, El-Sadr W, Lundgren J, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L; for the D:A:D and RESPOND Study Groups
   AIDS. 2026